{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-008810","form_type":"8-K","ticker":"STXS","cik":"0001289340","company_name":"Stereotaxis, Inc.","filed_at":"2025-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.225689+00:00","generated_at":"2026-05-25T16:59:53.155745+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Q4 revenue up 39% to $6.3M; expects double-digit revenue growth in 2025","bullets":["Q4 2024 revenue $6.3M (+39% YoY); full year $26.9M (+0.4% YoY).","Operating loss ($7.6M) in Q4; adjusted operating loss ($4.0M); net loss ($7.5M).","Cash $12.4M, no debt; positive free cash flow of $1.3M in Q4.","2025 guidance: double-digit revenue growth; recurring revenue to scale from $5M Q1 to $7M Q4.","Regulatory milestones: European MAGiC catheter approval, GenesisX first sale, China approvals."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-008810","json":"https://secwatch.observer/filing/0001493152-25-008810.json","markdown":"https://secwatch.observer/filing/0001493152-25-008810.md","text":"https://secwatch.observer/filing/0001493152-25-008810.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1289340/000149315225008810/0001493152-25-008810-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1289340/000149315225008810/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T16:59:53.155745+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}